GZNL-P36, CAS [[3089845-68-8]]

Produktübersicht

• Artikelname: GZNL-P36, CAS [[3089845-68-8]]
• Artikelnummer: MCE-HY-162484
• Hersteller Artikelnummer: HY-162484
• Alternativnummer: MCE-HY-162484-50MG,MCE-HY-162484-25MG,MCE-HY-162484-10MG,MCE-HY-162484-5MG,MCE-HY-162484-100MG,MCE-HY-162484-10MMX1ML
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

GZNL-P36 is an orally active inhibitor for SARS-CoV-2 papain-like protease (PLpro), with an IC50 of 6.45 nM. GZNL-P36 inhibits SARS-CoV and its variants with EC50 range from 58.2 nM to 2.66 µM. GZNL-P36 exhibits a peak plasma concentration Cmax of 549 ng/mL, a half-life T1/2 of 1.45 h and a bioavailability of 74.7% in CD-1 mouse. GZNL-P36 exhibits antiviral activity in SARS-CoV-2 XXB.1 infection in mouse[1].

Produkteigenschaften

• Molekulargewicht: 466.57
• Reinheit: 98.97
• CAS Nummer: [3089845-68-8]
• Formel: C29H30N4O2
• Target-Kategorie: SARS-CoV,Virus Protease

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound